HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David M Williams Selected Research

Xultophy

11/2018Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David M Williams Research Topics

Disease

13Type 2 Diabetes Mellitus (MODY)
05/2024 - 01/2015
13Neoplasms (Cancer)
11/2023 - 01/2005
12Aortic Dissection
01/2023 - 10/2002
12Aneurysm (Aneurysms)
01/2023 - 02/2006
11Thrombosis (Thrombus)
01/2023 - 04/2008
10Stroke (Strokes)
01/2023 - 05/2008
7Weight Loss (Weight Reduction)
05/2024 - 11/2015
7Rupture
09/2017 - 09/2006
6Obesity
04/2024 - 11/2015
6Pathologic Constriction (Stenosis)
01/2023 - 07/2003
5Overweight
03/2022 - 06/2015
5Aortic Diseases
06/2021 - 12/2006
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2024 - 11/2019
4Body Weight (Weight, Body)
12/2023 - 01/2011
4Hypertension (High Blood Pressure)
01/2023 - 12/2006
4Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2023 - 04/2010
4Aortic Aneurysm (Aneurysm, Aortic)
01/2023 - 11/2008
3Prediabetic State (Prediabetes)
03/2022 - 06/2015
3Hypoglycemia (Reactive Hypoglycemia)
01/2022 - 01/2015
3Pain (Aches)
02/2021 - 06/2017
3Heart Failure
01/2021 - 09/2020
3Cardiovascular Diseases (Cardiovascular Disease)
10/2020 - 11/2012
3Critical Illness (Critically Ill)
04/2020 - 12/2015
3Renal Insufficiency (Renal Failure)
07/2015 - 04/2010
3Paraplegia (Spastic Paraplegia)
04/2015 - 05/2010
3Aortic Rupture
07/2014 - 12/2009
3False Aneurysm (Pseudoaneurysm)
05/2010 - 05/2006
2Tobacco Use Disorder (Nicotine Dependence)
01/2023 - 12/2021
2Dyslipidemias (Dyslipidemia)
01/2023 - 11/2012
2Infections
11/2022 - 11/2022
2Inflammation (Inflammations)
01/2022 - 12/2020
2Shock
05/2021 - 12/2015
2Sepsis (Septicemia)
09/2019 - 03/2011
2Abdominal Aortic Aneurysm
11/2017 - 03/2003
2Superior Vena Cava Syndrome (Superior Vena Cava Obstruction)
11/2017 - 11/2017
2Penetrating Atherosclerotic Ulcer
11/2016 - 05/2006
2Renal Artery Obstruction (Renal Artery Stenosis)
05/2016 - 05/2013
2Carcinogenesis
01/2016 - 01/2016
2Spinal Cord Ischemia
07/2015 - 12/2009
2Weight Gain
01/2015 - 04/2010
2Coronary Artery Disease (Coronary Atherosclerosis)
07/2013 - 04/2010
2Paralysis (Palsy)
07/2013 - 05/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2023
1Hypothyroidism
09/2023
1Schizophrenia (Dementia Praecox)
01/2023
1Bone Marrow Failure Disorders
01/2023
1Fanconi Anemia (Fanconi's Anemia)
01/2023
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
12/2022
1Disease Progression
01/2022

Drug/Important Bio-Agent (IBA)

10Insulin (Novolin)FDA Link
02/2024 - 12/2015
8Glucose (Dextrose)FDA LinkGeneric
12/2022 - 01/2015
7DNA (Deoxyribonucleic Acid)IBA
11/2023 - 06/2009
7SodiumIBA
12/2022 - 01/2015
6EnzymesIBA
12/2023 - 02/2006
5Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021 - 01/2015
5CreatinineIBA
11/2020 - 04/2010
4semaglutideIBA
05/2024 - 10/2020
4Glucagon-Like Peptide 1 (GLP 1)IBA
01/2023 - 11/2018
4NicotineFDA Link
01/2023 - 04/2010
3Hormones (Hormone)IBA
09/2023 - 06/2020
3Contrast MediaIBA
05/2006 - 02/2003
2Glucagon-Like Peptide-1 ReceptorIBA
01/2023 - 03/2022
2SmokeIBA
01/2023 - 11/2007
2Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2009
2LiraglutideFDA Link
03/2022 - 11/2018
2insulin degludecIBA
01/2021 - 11/2018
2Biomarkers (Surrogate Marker)IBA
12/2020 - 11/2016
2Lactic Acid (Lactate)FDA LinkGeneric
11/2020 - 01/2019
2dapagliflozinIBA
10/2020 - 01/2015
2DiureticsIBA
10/2020 - 09/2020
2Blood Glucose (Blood Sugar)IBA
04/2020 - 03/2020
2Analgesics (Analgesic Drugs)IBA
04/2020 - 06/2017
2N 30IBA
01/2020 - 07/2014
2Polytetrafluoroethylene (Teflon)FDA Link
11/2017 - 11/2004
2Alkylating AgentsIBA
01/2016 - 01/2006
2O-(6)-methylguanineIBA
06/2014 - 05/2013
1Triglycerides (Triacylglycerol)IBA
12/2023
1Dihydrotachysterol (AT 10)IBA
12/2023
1Antipsychotic Agents (Antipsychotics)IBA
09/2023
1Antidepressive Agents (Antidepressants)IBA
09/2023
1HemosiderinIBA
01/2023
1MetalsIBA
01/2023
1AnticoagulantsIBA
01/2023
1CotinineIBA
12/2021

Therapy/Procedure

21Therapeutics
12/2022 - 11/2004
19Endovascular Aneurysm Repair
01/2023 - 05/2007
14Stents
01/2023 - 10/2002
9Drug Therapy (Chemotherapy)
03/2022 - 01/2005
6Tracheostomy
07/2015 - 12/2009
4Bariatric Surgery
04/2024 - 11/2015
4Catheters
07/2017 - 02/2003
4Resistance Training
01/2017 - 06/2014
3Glycemic Control
01/2023 - 01/2015
3Length of Stay
11/2022 - 01/2016
2Injections
12/2022 - 01/2021
2Critical Care (Surgical Intensive Care)
11/2022 - 05/2021
2Extracorporeal Membrane Oxygenation
04/2020 - 03/2016
2Vena Cava Filters (Inferior Vena Cava Filter)
03/2020 - 07/2017
2Cannula
03/2020 - 03/2016
2Nephrectomy
07/2018 - 12/2006